Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Ito Fukunaga M, Wiener RS, Toomey S, Wagner J, Shi Q, Balakrishnan K, Nguyen A, Nguyen D, McKee MD, Bankier AA, Sadasivam RS, Crawford SL, Han PK, Houston TK, Mazor KM. Previsit Preparation for Shared Decision-Making in Lung Cancer Screening in Primary Care Using a Paper Decision Aid and an Automated Text Messaging Program: Quasi-Experimental Pilot Study. JMIR Form Res. 2025 Sep 17; 9:e69044.
-
Fuster-Matanzo A, Pic?-Peris A, Bellv?s-Bataller F, Jimenez-Pastor A, Weiss GJ, Mart?-Bonmat? L, L?zaro S?nchez A, Bazaga D, Banna GL, Addeo A, Camps C, Seijo LM, Alberich-Bayarri ?. Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods. Eur Radiol. 2026 Mar; 36(3):2157-2185.
-
Reddington H, Ballinger Z, Guart J, Emmerick I, Crawford A, Maxfield M, Uy K, Lou F. National adoption of robotic-assisted thoracoscopic surgery for oncologic lung resections. J Robot Surg. 2025 Sep 04; 19(1):557.
-
Wilder FG, Bostock IC, Watkins A, Erfe JM, Bradley G, Erkmen C, Pereira S, Erhunmwunsee L. Social Determinants of Health in Thoracic Surgery: Critical Points for Understanding and Implementing Change. Ann Thorac Surg. 2025 Dec; 120(6):1188-1194.
-
Raquel-Cunha A, Pinheiro J, Marques RF, Font?o P, Cardoso-Carneiro D, Mendes A, Gomes INF, Laus AC, da Silva-Oliveira RJ, Reis RM, Martinho O. RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR-targeted therapies. Mol Oncol. 2025 Nov; 19(11):3205-3222.
-
Lo SB, Shin J, Holtze ME, Post KE, Eche-Ugwu IJ, Temel JS, Cooley ME, Greer JA. Characterization of multidimensional dyspnea in advanced lung cancer with moderate to severe dyspnea-related functional impairment: a latent profile analysis. Support Care Cancer. 2025 Jul 18; 33(8):700.
-
Chung C, Lee KN, Shin DW, Lee SW, Han K. Serum ?-glutamyl transferase as a novel risk indicator for lung cancer: insights from four million Koreans. Respir Res. 2025 Jul 10; 26(1):242.
-
Reddington H, Emmerick I, Crawford A, Briskin C, Maxfield M, Uy K, Lou F. Safety and Efficacy of Oncologic Second Pulmonary Resections: A Study of The Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2026 Feb; 121(2):300-309.
-
Song J, Chi KY, Jeon H, Chang YC, Xanthavanij N, Tang Z, Chang Y, Chiang CH, Lin YS, Lin S, Xu XH, Chiang CH. Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Oncology. 2026; 104(3):319-326.
-
Kant S, Caliz AD, Yoo HJ, Kaur G, Learnard H, Khalil HA, Davis RJ, Keaney JFJ. Mixed lineage kinase (MLK) controls tumor development and angiogenesis. Angiogenesis. 2025 May 02; 28(3):29.